LifeMD, Inc. (LFMD)

LifeMD Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	25.14	36.79	32.65	33.15	3.96	41.33
Cash & Short-Term Investments	25.14	36.79	32.65	33.15	3.96	41.33
Cash Growth	-30.60%	12.66%	-1.49%	737.26%	-90.42%	350.24%
Accounts Receivable	11.26	9.31	10.46	5.28	2.83	0.98
Receivables	11.26	9.31	10.46	5.28	2.83	0.98
Inventory	2.96	2.77	2.8	2.76	3.7	1.62
Other Current Assets	2.73	2.97	6.46	1.42	0.81	1
Total Current Assets	42.08	51.83	52.37	42.6	11.31	44.92
Property, Plant & Equipment	6.88	7.71	7.67	1.07	1.68	1.99
Other Intangible Assets	10.93	10.87	9.36	14.81	12.67	3.02
Other Long-Term Assets	-	-	6.7	-	-	-
Total Assets	59.89	70.41	76.1	58.48	25.67	49.92

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	18.16	14.15	10.9	11.08	10.11	9.06
Accrued Expenses	16.18	15.2	20.98	12.52	8.93	10.72
Short-Term Debt	-	-	-	0.33	2.8	0.06
Current Portion of Long-Term Debt	-	-	8.44	-	-	-
Current Portion of Leases	0.7	0.64	0.32	0.6	0.76	0.61
Current Unearned Revenue	10.79	10.81	17.1	8.83	5.55	1.5
Other Current Liabilities	0.78	0.78	9.65	1.42	3.24	0.87
Total Current Liabilities	46.61	41.57	67.4	34.78	31.37	22.83
Long-Term Debt	-	-	9.89	17.93	-	-
Long-Term Leases	5.32	5.68	6.28	0.07	0.57	1.18
Other Long-Term Liabilities	-	-	0.09	0.13	1.02	0.1
Total Liabilities	51.93	47.25	83.65	52.91	32.97	24.1

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	0.48	0.47	0.42	0.38	0.32	0.31
Additional Paid-In Capital	253.76	251.46	230.51	217.55	179.02	164.52
Retained Earnings	-246.11	-228.6	-239.85	-214.27	-190.56	-141.92
Treasury Stock	-0.16	-0.16	-0.16	-0.16	-0.16	-0.16
Total Common Equity	7.97	23.16	-9.08	3.51	-11.4	22.74
Minority Interest	-	-	1.53	2.06	-0.48	-1.03
Shareholders' Equity	7.97	23.16	-7.55	5.57	-7.31	25.82
Total Liabilities & Equity	59.89	70.41	76.1	58.48	25.67	49.92

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	6.02	6.32	24.93	18.93	4.13	1.85
Net Cash (Debt)	19.12	30.46	7.72	14.21	-0.17	39.48
Net Cash Growth	34.91%	294.43%	-45.67%	-	-	386.51%
Net Cash Per Share	0.41	0.68	0.19	0.42	-0.01	1.46
Filing Date Shares Outstanding	48.2	47.97	44.58	40.37	31.89	30.83
Total Common Shares Outstanding	47.82	46.66	42.19	38.26	31.45	30.6
Working Capital	-4.52	10.26	-15.03	7.82	-20.06	22.1
Book Value Per Share	0.17	0.50	-0.22	0.09	-0.36	0.74
Tangible Book Value	-2.97	12.29	-18.44	-11.3	-24.07	19.72
Tangible Book Value Per Share	-0.06	0.26	-0.44	-0.30	-0.77	0.64
Machinery	4.33	4.15	2.28	-	-	0.25

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Aug 5, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 7, 2026

Data Sources Report a data error